INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $202,432 | -15.3% | 4,964 | +50.8% | 0.01% | -38.9% |
Q1 2022 | $239,000 | -36.8% | 3,292 | +2.9% | 0.02% | -35.7% |
Q4 2021 | $378,000 | +4.1% | 3,200 | +18.3% | 0.03% | -6.7% |
Q3 2021 | $363,000 | -65.6% | 2,705 | -58.4% | 0.03% | -55.2% |
Q2 2021 | $1,054,000 | +90.9% | 6,508 | -5.3% | 0.07% | +67.5% |
Q1 2021 | $552,000 | -30.1% | 6,873 | -52.7% | 0.04% | -39.4% |
Q4 2020 | $790,000 | +164.2% | 14,531 | -3.3% | 0.07% | +120.0% |
Q3 2020 | $299,000 | +36.5% | 15,025 | +44.4% | 0.03% | 0.0% |
Q2 2020 | $219,000 | +43.1% | 10,405 | -16.8% | 0.03% | +36.4% |
Q1 2020 | $153,000 | -15.0% | 12,505 | +18.7% | 0.02% | -26.7% |
Q1 2019 | $180,000 | +27.7% | 10,534 | +2.1% | 0.03% | +11.1% |
Q4 2018 | $141,000 | -38.7% | 10,322 | +28.4% | 0.03% | -46.0% |
Q3 2018 | $230,000 | +1.8% | 8,042 | -2.4% | 0.05% | -13.8% |
Q2 2018 | $226,000 | +32.9% | 8,242 | 0.0% | 0.06% | +26.1% |
Q1 2018 | $170,000 | +5.6% | 8,242 | +2.5% | 0.05% | +7.0% |
Q4 2017 | $161,000 | -31.2% | 8,042 | 0.0% | 0.04% | -57.0% |
Q3 2017 | $234,000 | +23300.0% | 8,042 | -3.9% | 0.10% | – |
Q2 2017 | $1,000 | -99.1% | 8,370 | +1.1% | 0.00% | -100.0% |
Q1 2017 | $117,000 | – | 8,280 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |